Nephrotic syndrome

A Bagga, RN Srivastava - Pediatric nephrology, 2005 - books.google.com
Nephrotic syndrome is a common renal disorder. In developed countries, the incidence is
reported to be 20 to 40 per million population while in the Indian subcontinent it is estimated …

Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe

AJ Turley, B Gathmann, C Bangs, M Bradbury… - Journal of clinical …, 2015 - Springer
Introduction Complement immunodeficiencies (excluding hereditary angioedema and
mannose binding lectin deficiency) are rare. Published literature consists largely of case …

A validation of the 2018 revision of international Society of Nephrology/Renal pathology Society classification for lupus nephritis: a cohort study from China

J Tao, H Wang, XJ Yu, Y Tan, F Yu, SX Wang… - American journal of …, 2020 - karger.com
Background: A revision of the International Society of Nephrology/Renal Pathology Society
(ISN/RPS) classification for lupus nephritis has been published in 2018. The current study …

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

RA Kyle, JF San-Miguel, MV Mateos… - Hematology …, 2014 - hemonc.theclinics.com
Monoclonal gammopathy of undetermined significance (MGUS) is characterized by an M
spike less than 3 g/dL and a bone marrow containing fewer than 10% plasma cells and no …

Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification

S Alasfar, N Carter-Monroe, AZ Rosenberg… - BMC nephrology, 2016 - Springer
Background Membranoproliferative glomerulonephritis (MPGN) is an uncommon glomerular
disorder that may lead to end stage renal disease (ESRD). With new understanding of the …

Moss-produced, glycosylation-optimized human factor H for therapeutic application in complement disorders

S Michelfelder, J Parsons, LL Bohlender… - Journal of the …, 2017 - journals.lww.com
Genetic defects in complement regulatory proteins can lead to severe renal diseases,
including atypical hemolytic uremic syndrome and C3 glomerulopathies, and age-related …

Mass spectrometry based proteomics in the diagnosis of kidney disease

S Sethi, JA Vrana, JD Theis… - Current opinion in …, 2013 - journals.lww.com
Mass spectrometry based proteomics in the diagnosis of kidne... : Current Opinion in Nephrology
and Hypertension Mass spectrometry based proteomics in the diagnosis of kidney disease …

Overview of laboratory testing and clinical presentations of complement deficiencies and dysregulation

A Frazer-Abel, L Sepiashvili, MM Mbughuni… - Advances in clinical …, 2016 - Elsevier
Historically, complement disorders have been attributed to immunodeficiency associated
with severe or frequent infection. More recently, however, complement has been recognized …

C3 glomerulopathy and eculizumab: a report on four paediatric cases

C Lebreton, J Bacchetta, F Dijoud, L Bessenay… - Pediatric …, 2017 - Springer
Background Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe
glomerular disease. Diagnosis and Treatment Patients 1, 2 and 3 were diagnosed with …

[HTML][HTML] Rituximab use in adult glomerulopathies and its rationale

JE Santos, D Fiel, R Santos, R Vicente… - Brazilian Journal of …, 2019 - SciELO Brasil
Glomerulopathies are one of the leading causes of end-stage renal disease. In the last
years, clinical research has made significant contributions to the understanding of such …